SUVENPHAR.BOSUVENPHAR.BOBSE
Loading
SG&A Expense Growth AcceleratingAccelerating
Percentile Rank100
3Y CAGR+39.8%
Studio
Year-over-Year Change

Year-over-year SG&A expense growth

3Y CAGR
+39.8%/yr
Annual compound
Percentile
P100
Near historical high
vs 3Y Ago
2.7x
Strong expansion
Streak
1 yr
Consecutive growthAccelerating
PeriodValue
202583.55%
202414.65%
202318.94%
202230.55%
202112.82%
2020-14.63%
20190.00%